International Conference & Exhibition on Cancer Science & Therapy 

15-17 August 2011 |  Las Vegas, USA

OMICS Group invites all the participants across the globe to attend International Conference & Exhibition on Cancer Science & Therapy during 15-17 August 2011 Las Vegas, USA. Cancer Science-2011 is a remarkable event which brings together a unique and International mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions making the Congress a perfect platform to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe.

The conference highlights the following topics:

• Cancer Cell Biology • Cancer Immunology • Diagnostic and Prognostic Cancer Biomarkers • Carcinogenesis & Mutagenesis • Advances in Cancer Detection and Imaging • OMICS in Cancer Research • Cancer: Management & Prevention • Cancer Genetics • Cancer Therapy • Clinical Cancer Research • Regulatory and Economical Aspects in Cancer Research

Please register on/before 16 May 2011.....!

The BIO International Convention 

June 27-30, 2011 | Washington DC, USA

The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.

The event features keynotes and sessions from key policymakers, scientists, CEOs, and celebrities. Past speakers include President George W. Bush, President Bill Clinton, Michael J. Fox, Sir Elton John, Her Majesty Queen Noor of Jordan, and General Colin Powell, among many others. The Convention also features the BIO Business Forum (One-on-One Partnering), hundreds of sessions covering biotech trends, policy issues and technological innovations, and the world's largest biotechnology exhibition - the BIO Exhibition.

In 2007, 2008, and 2009 Tradeshow Week (TSW) named the BIO International Convention as one of the Fastest 50, a list of the fastest-growing trade shows. TSW editorial and research staff selected the Fastest 50 based on 50 percent total net square footage growth and 50 percent net growth between 2004 and 2008. In 2009, the BIO International Convention won the award for the fastest-growing Convention owned by a not-for-profit trade association.

10th International Congress on the Future of Breast Cancer  

July 7-10, 2011 | Hotel del Coronado | Coronado, CA

The 10th International Congress on the Future of Breast Cancer is an educational and scientific meeting that focuses on the clinical implications of breast cancer genetic and phenotypic subtyping. New data and promising studies that provide information about how to optimally individualize breast cancer therapy will be discussed, and controversial issues will be debated. In addition, strategies for optimizing the use of endocrine therapy, conventional chemotherapy, and targeted therapies will be presented, and evolving diagnostic approaches to identify the driving mutations or pathways in breast cancer will be thoroughly discussed along with the therapies targeting those mutations. Controversial issues in the surgical and radiotherapeutic management of breast cancer will also be discussed and debated. The format will include didactic sessions, question-and-answer panel discussions, and ample time for participant interaction with faculty.

July 21-24, 2011 | Park Hyatt Aviara | Carlsbad, CA 

Overview and Purpose
The 12th International Lung Cancer Congress is designed to provide participants with an update on advances in lung cancer research and therapy, including biology, pathology, screening, staging, personalized therapy, maintenance therapy, novel agents, and ongoing research in Cooperative Groups. Bringing key data from international oncology conferences to participants, the congress will emphasize the importance of personalized therapy and address other current topics of interest. State-of-the-art treatment for early-stage locally advanced and metastatic lung cancer will be discussed. In addition to non–small-cell lung cancer (NSCLC), the congress will address therapy for small-cell lung cancer (SCLC) and mesothelioma. A regular feature of the International Lung Cancer Congress is an update of research efforts from major Cooperative Groups from the United States, Europe, and Asia. The format of the meeting will include didactic lectures from internationally renowned leaders, debates and discussions on controversial topics, extensive panel discussions with case scenarios, multidisciplinary tumor boards, question-and-answer sessions, and afternoon translational workshops focusing on future strategies in development for the treatment of lung cancer.

The 4th International Biopharmaceutical Industry Development Innovation Forum  

April 21-22, 2011 | Shanghai Pudong, China

The 4^th International Biopharmaceutical Industry Development Innovation Forum & International Innovative drug research and translational medicine Summit, organized by Sino-EU Chemical Manufacturers Association Biomedical Committee（SEBMC),  will be held on Apr. 21^st -22^nd, 2011 at Renaissance Shanghai Pudong Hotel. At that time, more than 400 representatives and experts from the USA, Europe, China, Asia-pacific and international leading drug and medical specialists who engage on biopharmaceuticals, new drug research, innovative drug CRO, clinical medicine R&D and translational medicine will attend. This forum will focus on global Innovative bio-pharmaceutical R&D innovation and human health, the antibody-based drugs, new vaccines, genetic engineering drugs, antibody humanization technology, new drug development technology, recombinant human protein, gene therapy, cell therapy and interferon and the development and application of medical innovation, anti-infection drugs, anti-diabetic drugs and the cardiovascular system drugs, nervous system drugs, anti-drug discovery and treatment of major diseases, drug discovery, drug design, drug clinical trials, patents and licensing, innovation and outsourcing of drug and clinical trials cooperation in Asia and biopharmaceutical industry development. 

The 11th annual World Vaccine Congress Washington  

April 11-14, 2011 | Washington DC, USA

As industry continues to re-address the scientific and strategic boundaries of vaccine development, the implications for how these pioneering advances impact domestic and international immunization and market growth are profound.

In 2010 over 485+ delegates came to the 10th annual World Vaccine Congress Washington! In 2011 you will have the opportunity to hear from North America’s leading governmental stakeholders, business leaders and scientific stakeholders as they continue to enhance the scientific and strategic innovation behind a burgeoning vaccine industry.